Pfizer’s Metsera acquisition to spur Chinese search for new weight drugs
- Posted on September 26, 2025
- By South China Morning Post
- 7 Views
Pfizer’s Metsera acquisition to spur Chinese search for new weight drugs
Deal, worth up to US$7.3 billion, will encourage ongoing investment by mainland players but not draw in new players, analysts say.
